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Background: The leptin receptor-deficient db/db mouse is a well-established type II diabetes animal model used to
investigate diabetic cardiomyopathy. Previous reports have documented diabetic cardiomyopathy is accompanied by
cardiac structural and functional abnormalities. To better elucidate early or subtle changes in cardiac performance in
db/db mice, we used speckle tracking echocardiography to assess systolic myocardial strain in vivo with diabetic db/
db mice in order to study early changes of left ventricle contractile function in type II diabetes model.
Methods: Male diabetic db/db mice and age-matched control mice from C57BL/6J strain at 8,12 and 16 weeks of
age were subjected to echocardiography. At the midpapillary level in the parasternal left ventricular short-axis view, end
diastolic and systolic left ventricular diameter, interventricular septal thickness and posterior wall thicknesses, ejection
fraction, fractional shortening were determined by M-mode echocardiography. Using speckle-tracking based strain
analysis of two-dimensional echocardiographic images acquired from the parasternal short-axis views at the
mid-papillary level, systolic global radial and circumferential strain values were analyzed.
Results: There was no significant difference in interventricular septal thickness, posterior wall thicknesses, end diastolic
and systolic left ventricular diameter, ejection fraction and fractional shortening between db/db and age-matched
control mice at 8,12 or 16 weeks of age (P > 0.05). At 8 and 12 weeks of age, there was no significant difference in left
ventricular radial strain and circumferential strain between db/db mice and age-matched controls (P > 0.05). But at 16
weeks of age, the left ventricular radial strain and circumferential strain in db/db mice were lower than in control mice
(P < 0.01).
Conclusion: The present study shows that speckle tracking echocardiography can be used to evaluate cardiac
functional alterations in mouse models of cardiovascular disease. Radial and circumferential strain are more sensitive
and can be used for detection of early left ventricular contractile dysfunction in db/db type II diabetic mice.
Keywords: Diabetic cardiomyopathy, db/db mice, Echocardiography, Strain, Cardiac functionBackground
The most prevalent form (90%) of diabetes mellitus is
Type II (non-insulin-dependent) diabetes [1]. Epidemio-
logical and clinical evidence shows that type II diabetes
mellitus is a prevalent disease that results in a marked in-
crease in cardiovascular complications that are in part due
to a specific cardiomyopathy, characterized by ventricular
dysfunction in the absence of atherosclerotic coronary* Correspondence: rong4020@126.com
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unless otherwise stated.heart disease or hypertension [2,3]. Abnormalities in car-
diac function and structure in diabetic subjects have been
demonstrated in animal [4-7] and human studies [8-11].
However, there is still controversy regarding the severity
or time of appearance of cardiac impairment following the
appearance of type II diabetes.
Most reports of diabetes-induced cardiac dysfunction
have used insulin-deficient (TypeI) models [12-14]. Rela-
tively few studies on cardiac function have been conducted
with type II diabetic animal models [15]. The leptin
receptor-deficient db/db mouse is a well established model
of type II diabetes, with obesity and insulin resistancehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2261/14/141[16,17]. In vivo evidence for left ventricle structure and
dysfunction in diabetic mice is commonly obtained from
conventional echocardiography (M-mode, 2D, Doppler)
[18,19], which is typically considered late manifestations of
disease and insensitive to detect subtle left ventricle dys-
function. The presence of resting abnormalities of sensitive
indices of myocardial function measured by speckle track-
ing echocardiography (STE) has been attributed to a sub-
clinical diabetic cardiomyopathy. Tracking the movement
of myocardial tissue, STE is used to determine longitudinal
strain, radial and circumferential strain for detecting global
and regional myocardial dysfunction [20]. Therefore, the
objective of this study was to use STE to assess systolic
myocardial strain in vivo with diabetic db/db and control
mice in order to study early changes of left ventricle con-
tractile function in type II diabetes model.
Methods
All studies have been approved by Beijing Anzhen Hos-
pital Ethics Committee and performed in accordance with
the ethical standards.
Animals
Experiments were performed on 8-, 12- and 16-wk male
homozygous diabetic (db/db) (n = 8 in each week) and
age-matched heterozygote non-diabetic (Control) mice
(n = 8 in each week), obtained from Beijing University
(Beijing, China). The control and diabetic mice (Figure 1)
used in this study were the C57BL/6J strain. The mice were
housed in groups and allowed ad libitum access to water
and standard laboratory mouse chow. All the experimental
procedures described below adhered strictly to the guidelines
set forth by the National Science and Technology Commis-
sion of China and approved by the institutional ethics com-
mittee. The experiment conformed to the Animal Research:
Reporting In Vivo Experiments (ARRIVE) guidelines.
Conventional echocardiographic measurements
Before examination, all mice were anesthetized in a closed
chamber with 3% isoflurane in oxygen for 2 to 5 minutes
until immobile. Each mouse was weighed, carefully shaved
and taped supine to ECG electrodes on a heated procedureFigure 1 12-wk male non-diabetic C57BL/6 mice (A) and age-
matched diabetic db/db mice (B).board with isoflurane (at 2%) supplied by a nose cone con-
nected to the anesthesia machine. Warm ultrasound trans-
mission gel was liberally applied to ensure optimal image
quality. Echocardiography was performed using a 18 to
38 MHz linear-array transducer with a digital ultrasound
system (Vevo2100 Imaging System, VisualSonics, Toronto,
Canada). Standard two-dimensional gray-scale image and
M-mode image at the mid-papillary level in the parasternal
left ventricle short-axis view were obtained during each
echocardiographic examination. Conventional echocardio-
graphic image measurements were performed offline. All
image acquisitions and offline measurements were con-
ducted by a single investigator who was blinded to animal
groups. All M-mode measurements were performed in
end-diastole and end-systole according to the leading
edge-to-leading edge method of the American Soiety of
Echocardiography [21]. Conventional measurements of the
left ventricle (LV) included: end-diastolic diameter (LVEDD),
end-systolic diameter (LVESD), interventricular septal thick-
ness (IVST) and posterior wall thicknesses (LVPWT), ejec-
tion fraction (LVEF), fractional shortening (LVFS).
LV mass =1.053 × [(LVEDD+LVPWT+ IVST)3–LVEDD3].
All data are the average of at least two separate scans, each
scan representing the average of three selected beats.
Novel speckle tracking echocardiography (STE) based
strain measures of myocardial deformation
Using STE based strain analysis of 2D gray scale echocar-
diographic images acquired from the parasternal short-
axis views (at the mid-papillary level), strain analyses
were quantified in the radial and circumferential axes.
All images were acquired at a frame rate of >200 frames
per second and at an average depth of 11 mm. Strain ana-
lyses were conducted by the same trained investigator on
all animals according to the protocol detailed in the Online
Data Supplement and using a speckle-tracking algorithm
provided by VisualSonics (VevoStrain, VisualSonics). In
brief, suitable B-mode loops were selected from digitally
acquired echocardiographic images based on adequate
visualization of the endocardial border and absence of
image artifacts. Three consecutive cardiac cycles were
selected for analysis based on image quality. Semiauto-
mated tracing of the endocardial and epicardial borders
were performed and verified over all 3 cardiac cycles
and then corrected as needed to achieve good quality
tracking throughout each cine loop. Tracked images
were then processed in a frame-by-frame manner for
strain measurements. Strain measures were averaged
over the obtained cardiac cycles, resulting in curvilinear
strain data (Figures 2 and 3). Short-axis view of the LV myo-
cardium was divided into 6 standard anatomic segments for
regional speckle-tracking based strain analysis throughout
the cardiac cycle. Peak radial and circumferential strain mea-
surements were recorded from each of the 6 standard
Figure 2 Radial strain curves in 16-wk non-diabetic C57BL/6 mice (A) and age-matched diabetic db/db mice (B).
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global radial and circumferential strain values, peak strain
measurements were averaged across all 6 segments.
Glucose, heart weight and body weight measurements
Mice were fasted for 8-hrs during the light cycle and
blood was drawn from the tail vein. Blood glucose was
measured using the glucometer (Johnson & Johnson).
After ultrasound detection, mice were sacrificed. Im-
mediately after death, wet heart weight (HW) and body
weight (BW) were measured.
Statistical analysis
All analyses were performed with the use of SPSS 16.0
software. Resulting values are expressed as mean ± SD.Differences in conventional echocardiographic parame-
ters and strain parameters between diabetic (db/db) and
control mice of the same age were determined by means
of an unpaired t test. Unpaired one-way ANOVA was
used to test all parameters in different weeks of mice
from the same genotype. Differences between means
were regarded as statistically significant at P value <0.05.
Results
Body weight, heart weight, blood glucose and heart rate
measurements
Body weight (BW), heart weight (HW), blood glucose and
heart rate data of db/db and control mice (n = 8 for each
group) were summarized in Table 1. The diabetic mice had
larger body weight and fasting blood glucose compared to
Figure 3 Circumferential strain curves in 16-wk non-diabetic C57BL/6 mice (A) and age-matched diabetic db/db mice (B).
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difference in heart weight and heart rate between db/db
mice and age-matched controls (P > 0.05). HW/BW of db/
db mice significantly decreased compared to age-matched
controls because of increased BW (P < 0.01).
Conventional echocardiographic measurements of left
ventricle structure and systolic function
Conventional echocardiographic parameters of left ven-
tricle structure and systolic function in db/db and control
mice were summarized in Table 2. Echocardiography
showed that the thickness of interventricular septum and
posterior wall were similar at 8, 12 or 16 weeks of age be-
tween db/db and control mice (P > 0.05). There was no
significant difference in LVEDD, LVESD, LVEF, LVFS andLV mass at the same weeks of age between db/db and
control mice (P > 0.05).
LVAWT, LVPWT, LVEDD, LVESD, LVEF and LVFS
did not change with age for both dbdb and C57BL/6
mice (P > 0.05).
STE measurements of myocardial deformation
Using speckle tracking echocardiography, systolic glo-
bal radial and circumferential strain values from the
parasternal short-axis views at the mid-papillary level
in db/db and control mice were obtained (Table 3 and
Figure 4). At 8 and 12 weeks of age, there was no sig-
nificant difference in left ventricular radial strain and
circumferential strain between db/db mice and con-
trols. But at 16 weeks of age, the left ventricular radial
Table 2 M-mode parameters of the LV (parasternal short-
axis view) in control and db/db mice
Variables Control Db/db P value
8 weeks
Heart Rate(bmp) 397.50 ± 25.46 378.22 ± 37.25 P > 0.05
IVST(mm) 0.71 ± 0.05 0.66 ± 0.05 P > 0.05
LVPWD(mm) 0.69 ± 0.06 0.68 ± 0.05 P > 0.05
LVEDD(mm) 3.79 ± 0.23 3.68 ± 0.28 P > 0.05
LVESD(mm) 2.41 ± 0.27 2.26 ± 0.23 P > 0.05
LVEF(%) 66.25 ± 7.43 69.15 ± 7.25 P > 0.05
LVFS(%) 36.44 ± 5.13 38.39 ± 5.58 P > 0.05
LV mass(mg) 90.39 ± 11.15 83.32 ± 10.89 P > 0.05
12 weeks
Heart Rate(bmp) 392.50 ± 44.99 388.77 ± 39.02 P > 0.05
IVST(mm) 0.68 ± 0.06 0.71 ± 0.05 P > 0.05
LVPWD(mm) 0.70 ± 0.06 0.69 ± 0.06 P > 0.05
LVEDD(mm) 3.90 ± 0.26 3.82 ± 0.18 P > 0.05
LVESD(mm) 2.49 ± 0.31 2.37 ± 0.20 P > 0.05
LVEF(%) 65.91 ± 7.54 68.51 ± 5.25 P > 0.05
LVFS(%) 36.01 ± 5.38 37.99 ± 4.53 P > 0.05
LV mass(mg) 93.21 ± 9.52 92.24 ± 13.44 P > 0.05
16 weeks
Heart Rate(bmp) 381.25 ± 21.94 391.44 ± 39.81 P > 0.05
IVST(mm) 0.72 ± 0.03 0.71 ± 0.03 P > 0.05
LVPWD(mm) 0.69 ± 0.04 0.69 ± 0.05 P > 0.05
LVEDD(mm) 3.94 ± 0.19 3.77 ± 0.35 P > 0.05
LVESD(mm) 2.53 ± 0.21 2.36 ± 0.28 P > 0.05
LVEF(%) 66.78 ± 4.17 67.55 ± 7.79 P > 0.05
Table 1 Characteristics of control and db/db mice
Variables Control Db/db P value
8 weeks
Body Weight (g) 22.26 ± 1.08 40.19 ± 1.96 P < 0.0001
Heart Weight (g) 0.12 ± 0.01 0.12 ± 0.01 P > 0.05
HW/BW 0.005 ± 0.0009 0.003 ± 0.0004 P < 0.0001
fasting blood
glucose(mmol/L)
2.52 ± 0.50 7.62 ± 1.15 P < 0.0001
12 weeks
Body Weight (g) 25.71 ± 1.41 47.82 ± 2.67 P < 0.0001
Heart Weight (g) 0.13 ± 0.01 0.13 ± 0.01 P > 0.05
HW/BW 0.005 ± 0.0002 0.003 ± 0.0002 P < 0.0001
fasting blood
glucose(mmol/L)
2.15 ± 0.57 8.12 ± 1.22 P < 0.0001
16 weeks
Body Weight (g) 27.14 ± 1.95 43.42 ± 2.05 P < 0.0001
Heart Weight (g) 0.13 ± 0.02 0.12 ± 0.01 P > 0.05
HW/BW 0.005 ± 0.0006 0.002 ± 0.0002 P < 0.0001
fasting blood
glucose(mmol/L)
2.66 ± 0.29 12.71 ± 2.47 P < 0.0001
The table shows the diabetic mice have larger body weight and fasting blood
glucose compared to control mice at 8, 12 or 16 weeks of age.
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lower than in control mice (P < 0.01).
Left ventricular radial strain and circumferential strain
did not change with age for C57BL/6J mice (P > 0.05).
Comparison of 8- and 12-wk db/db mice, left ventricular
radial strain and circumferential strain were significantly
reduced in 16-wk db/db mice (P < 0.01).LVFS(%) 36.57 ± 3.30 37.25 ± 6.05 P > 0.05
LV mass(mg) 97.81 ± 8.31 90.98 ± 14.37 P > 0.05
The diagram shows no significant difference in the measurements of heart
rate, left ventricular dimensions, thickness and function parameters by M-
mode echocardiography in dbdb and control mice at 8,12 and 16 weeks of
age (P > 0.05).Discussion
Diabetic db/db mice provide one of more commonly used
animal models used to investigate diabetic cardiomyop-
athy, with obesity and insulin resistance [16,17]. In the
literature, db/db mice develop severe dabetes by 8 weeks
of age [22,23]. Our study showed at 8, 12 and 16 weeks
of age, diabetic (db/db) mice weighed significantly more
than control mice. As expected, at 8 weeks of age dia-
betic mice had significantly elevated fasting blood glu-
cose with hyperglycemia.
Diabetic cardiomyopathy is accompanied by functional,
structural and pathologic cardiac characteristics. Echocar-
diography is a noninvasive method that can assess cardiac
function in mice [24-26]. We used M-mode measurements
of LV dimensions in end systole and end diastole and myo-
cardium thickness to provide information on morphology
and systolic function. However, we observed that left ven-
tricular dimensions and myocardium thickness in db/db
mice were not significantly increased until 16 weeks of age
compared to control mice. The parameters reflecting theleft ventricular systolic function such as LVEF and LVFS
could not be detected unchanged in db/db mice. These
findings were supported by Barouch and colleages as
they reported echocardiographically in 24-week-old db/db
mice on C57BL/6J background an unchanged LVEF and
FS [27]. However, conventional echocardiographic mea-
sures lack sensitivity for capturing subtle variations in left
ventricular (LV) performance. Changes in LV structure
and global function, when detected by conventional
echocardiographic parameters, are typically considered
late manifestations of disease.
Speckle tracking echocardiography (STE) is a novel, non-
Doppler-based technique used to detect myocardial wall
motion and myocardial deformation. In clinical studies
Table 3 Radial and circumferential strain values in control
and db/db mice by STE measurements
Variables Control Db/db P value
8 weeks
Radial strain(%) 43.43 ± 7.03 42.73 ± 6.77 P > 0.05
Circumferential strain(%) -29.92 ± 2.47 -29.95 ± 4.01 P > 0.05
12 weeks
Radial strain(%) 45.43 ± 8.36 45.14 ± 9.75 P > 0.05
Circumferential strain(%) -30.20 ± 3.83 -28.75 ± 4.82 P > 0.05
16 weeks
Radial strain(%) 42.37 ± 4.40 31.19 ± 3.95 P < 0.01
Circumferential strain(%) -30.71 ± 2.24 -22.54 ± 3.57 P < 0.01
The table shows at 8 and 12 weeks of age, there was no significant difference
in left ventricular radial strain and circumferential strain between db/db mice
and age-matched controls (P > 0.05). At 16 weeks of age, radial strain and
circumferential strain in db/db mice were lower than in control mice
(P < 0.01).
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proved accuracy of myocardial contractility and quanti-
fication of global and regional myocardial function.
Cardiovascular risk factors result in impaired strain
measures before the development of decreased LVEF or
ventricular dilatation [28,29]. In experimental studies, the
adoption of strain analysis in small animal models has
been limited, primarily because of technical differences in
imaging mice versus humans, including limited echocar-
diographic views, translational motion during image ac-
quisition, and the effect of very high heart rates. However,
recently developed speckle-tracking based techniques now
allow for angle-independent, reproducible, and accurate
strain measurements that may be applied to mice. STE
can accurately predict pathophysiology during the evolu-
tion of MI [30,31] and TAC-induced heart failure in mice
[32]. LV contraction is a complex process involving de-
formation resulting in shortening in 3 normal directions;
longitudinal, radial strain (RS) and circumferential strain
(CS). RS and CS are more influenced by transmural fiberFigure 4 The graphs shows at 8 and 12 weeks of age, there was no s
circumferential strain (B) between db/db mice and age-matched cont
circumferential strain (B) in db/db mice were lower than in control mice (P
diabetic C57BL/6 mice; db/db, db/db mice.dysfunction (especially the midmyocardium), and are gen-
erally more suited for identifying dysfunction in ventricles
with reduced left ventricle systolic function. Therefore our
study used STE to assess systolic myocardial radial strain
and circumferential strain with diabetic db/db and control
mice. With the use of STE, we were able to detect lower
myocardial radial and circumferential strain in db/db mice
at 16 weeks of age, indicating LV contractile function was
indeed abnormal in this type II diabetic mice. Our study
showed that subtle abnormalities in strain were associated
with the presence of diabetic cardiomyopathy even in the
setting of normal cardiac structure and function by con-
ventional measures. In other words, the present study
therefore indicate that radial and circumferential strain
are more sensitive and can be used for detection of early
LV contractile dysfunction in this type II diabetic mice
model.
It should be mentioned that the HRs play an important
role in the determination of cardiac function in mice by
echocardiography. Inhalation anesthesia with isoflurane
has currently been considered ideal and useful for experi-
mental studies in the mouse because of its rapid conduc-
tion, easy control of the depth of anesthesia, and stable
HRs during observations [33,34]. Usually, the range of
HRs in anesthetic mice for echocardiography is 300 to 550
beats per minute (bpm), as reported [35]. In our experi-
ment HRs were not significantly different between db/db
mice and age-matched controls. Heart rate values of our
mice were low but in this range. It may be related to
anesthesia time.
Conclusion
The present study shows that speckle tracking echocar-
diography can be used to evaluate cardiac functional al-
terations in mouse models of cardiovascular disease.
Radial and circumferential strain are more sensitive and
can be used for detection of early left ventricular con-
tractile dysfunction in db/db type II diabetic mice.ignificant difference in left ventricular radial strain (A) and
rols (P > 0.05). At 16 weeks of age, radial strain (A) and
< 0.01). RS indicates radial strain; CS, circumferential strain; C57, non-
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